Georgetown is a charming area with Federal-style architecture, cobblestone streets and fashion and design shops. The dining scene is defined by upmarket restaurants and waterfront seafood spots, while nightlife spans boisterous college bars, traditional taverns and intimate live music lounges. Georgetown Waterfront Park has a riverside promenade and gardens, and there's a bike path along the C&O Canal. ― Google

During the past decade, Georgetown conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Georgetown" #1 sponsor was "Catherine Bollard" with 1 trials, followed by "Celularity Incorporated" with 1 trials sponsored, "Incyte Corporation" with 1 trials sponsored, "Matrix Biomed, Inc." with 1 trials sponsored and "Regeneron Pharmaceuticals" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Georgetown" #1 collaborator was "Blood and Marrow Transplant Clinical Trials Network" with 1 trials as a collaborator, "Children's National Research Institute" with 1 trials as a collaborator, "MedStar Georgetown" with 1 trials as a collaborator, "National Cancer Institute (NCI)" with 1 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Georgetown" are "Bladder Cancer" (1 trials), "Colorectal Cancer (CRC)" (1 trials), "Gastric Cancer" (1 trials), "Glioblastoma" (1 trials) and "Glioblastoma Multiforme" (1 trials). Many other conditions were trialed in "Georgetown" in a lesser frequency.

Most popular intervention types in "Georgetown" are "Drug" (4 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Pembrolizumab" (3 trials), "Bone Marrow Transplant" (1 trials), "CMP-001" (1 trials), "CYNK-101" (1 trials) and "Cyclophosphamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Georgetown" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Georgetown". 1 are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Georgetown, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Georgetown, 3 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".